Avantor Inc.

Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The firm operates through the following segments: the Americas, Europe, and AMEA. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Avantor meets Q4 expectations, eyes bioproduction growth in 2023

Avantor delivered solid financial performance in Q4 and exceeded full-year revenue targets.
The company's focus on operational enhancements and global expansion supports future growth.
Challenges in the first quarter are being addressed with a focus on productivity and cost management.
Opportunities in bioproduction growth, M&A, and working capital improvements position Avantor for success.

Avantor Inc. reports Q1 revenue decline, eyes semiconductor market rebound

Avantor Inc. navigated challenges in Q1 with revenue declines due to destocking and semiconductor downturn, while showcasing strengths in innovation and acquisitions performance.
Management's confidence in the long-term strategy and focus on margin improvement present opportunities for growth and recovery in 2023, despite ongoing market challenges.
Strategic approaches to address destocking headwinds and market dynamics in different regions position Avantor Inc. for potential growth and resilience in the coming quarters.
Overall, Avantor Inc. faces challenges from market uncertainties but remains poised to leverage opportunities for growth, innovation, and margin improvement in the evolving landscape.

Avantor Inc. reports Q2 revenue decline, focuses on cost controls

Avantor Inc. faced revenue and EPS cuts in Q2 2023, driven by market challenges in biopharma and semiconductors. The company focused on cost savings, debt reduction, and operational efficiency. Challenges included limited visibility in research space and mid- to high single-digit organic decline in bioproduction.

Avantor Inc. reports Q3 revenue contraction, eyes growth opportunities

Avantor Inc. navigated challenges in Q3 2023 with a focus on growth and operational improvements.
Management's cautious yet optimistic stance reflects a strategic approach to customer sentiment and inventory health.
Outlook for 2024 remains uncertain, but the company is positioned to capitalize on opportunities in key markets.
Analyst questions addressed various topics, highlighting the company's proactive engagement with stakeholders.

Avantor Inc. exceeds Q4 expectations, eyes cost savings and margin growth

Avantor Inc. delivered solid Q4 results, focusing on executing business model transformation and driving growth strategy. Despite challenges in market conditions and revenue decline, the company is optimistic about cost-saving initiatives and margin improvement opportunities.

Avantor Inc. reports Q1 revenue decline but optimistic on growth

Avantor Inc. delivered mixed performance in Q1 2024 with revenue decline but strong margin and debt reduction. Despite challenges in certain segments and regions, the company remains optimistic about growth opportunities in key markets and cost-saving initiatives.

Avantor reports solid Q2 earnings, eyes growth in Bioprocessing segment

Avantor Inc.'s Q2 2024 performance showcased solid revenue, margin improvement, and strong segmental growth. While facing challenges in organic revenue decline and segmental performance, the company's focus on cost transformation and positive outlook signal resilience and potential for growth. Avantor's opportunities lie in leveraging Bioprocessing momentum and cost-saving initiatives for sustained performance enhancement.

Avantor Inc. reports solid Q3 performance and accelerates growth strategies

Avantor's Q3 performance reflects resilience and strategic focus amidst market challenges, with notable achievements in revenue, margin, and divestiture.
The company's strengths in innovation, operational excellence, and market positioning position it well for long-term growth and profitability.
While facing challenges in certain segments and cost transformation, Avantor's opportunities in renewable energy, cash flow, and market growth are promising.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the following geographical segments: the Americas, Europe, and AMEA. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

RADNOR, Pa. and SCHWABMÜNCHEN, Germany, April 12, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that it has entered into a definitive agreement to acquire privately held Ritter GmbH and its affiliates in an all-cash transaction with an upfront equity purchase price of approximately €890 million subject to final adjustments at closing and additional payments based on achieving future business performance milestones.

Avantor® to Acquire Ritter GmbH and its Affiliates; Expands Proprietary Offering for Diagnostic and Drug Discovery Workflows

RADNOR, Pa., March 31, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the first quarter 2021 after the market closes on Wednesday, April 28, 2021, and will hold a conference call at 5:00 p.m.

Avantor® to Report First Quarter 2021 Earnings and Host Earnings Call on Wednesday, April 28, 2021

RADNOR, Pa., March 18, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that Moody's Investor Services upgraded its Corporate Family Rating (CFR) to 'Ba3'/Stable Outlook.

Avantor® Announces Credit Rating Upgrade by Moody's Investors Services

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

NB Private Equity: Monthly NAV Update - February 2021

RADNOR, Pa., Feb. 22, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the Raymond...

Avantor® to Participate at the Raymond James 42nd Annual Institutional Investor Conference

Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q4 2020 Results - Earnings Call Transcript

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 11.54% and 0.14%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Avantor, Inc. (AVTR) Q4 Earnings and Revenues Beat Estimates

RADNOR, Pa., Feb. 3, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the quarter and year...

Avantor® Reports Fourth Quarter and Full-Year 2020 Results

Does Avantor, Inc. (AVTR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Avantor, Inc. (AVTR) Is Up 5.42% in One Week: What You Should Know

Avantor, Inc. (AVTR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

All You Need to Know About Avantor, Inc. (AVTR) Rating Upgrade to Buy

Avantor, Inc. (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Avantor, Inc. (AVTR) Keep the Earnings Surprise Streak Alive?

RADNOR, Pa., Jan. 11, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for...

Avantor® to Report Fourth Quarter and Full Year 2020 Earnings and Host Earnings Call on Wednesday, February 3, 2021

RADNOR, Pa., Jan. 11, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, provided preliminary unaudited revenues and free cash flow...

Avantor® Announces Preliminary Fourth Quarter Unaudited Revenues and Estimated Free Cash Flow

Becton, Dickinson and Co.

Johnson & Johnson

Moderna

Pfizer

Thermo Fisher Scientific

West Pharmaceutical Services

The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.

7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible

HCA Healthcare

Hologic

Catalent

Guardant Health Inc

As is the case every year, the major Wall Street firms we cover here at 24/7 Wall St.

Analysts' Top Health Care Stocks to Buy Could Be Big 2021 Winners

RADNOR, Pa., Dec. 17, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, is setting science in motion for goodness by giving back to...

Avantor® Sets Science in Motion for Goodness with Donations and Grants to Community-Based Organizations

CryoPort

McKesson

Excited about the Covid-19 vaccines from Pfizer and Moderna? You'll be waiting a long time unless the vaccines can be shipped at 94 degrees below zero.

Ultra-Cold Freezer Makers To Profit From Covid-19 Vaccine Rush

Avantor has had a stellar year, leveraging their diverse portfolio to retain recurring revenue over the 3rd quarter. Each segment of the portfolio remains exposed less than 3%, whilst allowing exposure to COVID-19-related tailwinds.

Avantor: Diversified Portfolio Mix Should Drive Upside From Q3 Onwards

Caesars Entertainment

Expedia

Fortive

GoodRx Holdings

Microsoft

PG&E

Pinterest

Planet Fitness

TransDigm

In this article we'll take a closer look at the Top 10 Stocks Billionaire Daniel Loeb Just Bought. If you're impatient to see the pinnacle of the list, you can skip ahead to the  Top 5 Stocks Billionaire Daniel Loeb Just Bought .

Top 10 Stocks Billionaire Daniel Loeb Just Bought

In this article we are going to use hedge fund sentiment as a tool and determine whether Avantor, Inc. (NYSE:AVTR) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments and it is a fact that hedge funds' picks don't beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

Was The Smart Money Right About Loading Up On Avantor, Inc. (AVTR)?

Avantor (AVTR) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Avantor (AVTR) in Focus: Stock Moves 6% Higher

RADNOR, Pa., Nov. 5, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced the pricing of...

Avantor® Announces Pricing of Upsized Secondary Offering

RADNOR, Pa., Oct. 30, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced today the pricing of the previously...

Avantor® Announces Upsizing and Pricing of Offering of €650.0 Million of Senior First Lien Notes

Avantor, Inc. (AVTR) CEO Michael Stubblefield on Q3 2020 Results - Earnings Call Transcript

Eagle Materials

Freeport-McMoRan

Huntsman

LyondellBasell Industries

Newmont Mining

Royal Gold

RPM International

Scotts Miracle-Gro

These are the materials stocks with the best value, fastest growth, and most momentum for November.

News for Avantor Inc. Stock (AVTR)